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Abstract 
Nanodiscs, engineered lipoparticles composed of a lipid bilayer and two surrounding 
amphipathic proteins, have been utilized to house and solubilize integral membrane proteins and 
other molecules with large hydrophobic groups which limit their aqueous solubility. In the 
experiments described herein, lipids from the Nanodiscs’ bilayer, gadolinium chelates and 
integral membrane proteins were analyzed for their incorporation and stability within the 
Nanodisc structure.  Four techniques are described for quantification of the exchange of lipids 
between Nanodiscs over time, including: scintillation counting, imaging proximity assay, NMR 
and TLC MALDI-MS.  Additionally, the extent and longevity of inclusion of the hydrophobic 
gadolinium-chelate “C3lipo” doped into the Nanodisc bilayer was analyzed and preliminary cell 
uptake studies were performed.  Finally, the incorporation of proteins from rat liver and fetal 
bovine brain membranes into Nanodiscs to create soluble membrane protein libraries is 
discussed. 
  
 iii 
 
Acknowledgements 
There are many people without whom this thesis would never have come to be and whose 
influence, both direct and indirect, I truly appreciate. I’d like to thank Prof. Steve Sligar for the 
opportunity to work and learn in his lab. Mark McLean, Yelena Grinkova and Ilia Denisov I 
thank for their patient help and instruction; Abhi Luthra, Mike Gregory, Xin Ye and Michael 
Marty for their help and comradery both in Morrill Hall and on the ski slopes.  Thank you to Ivan 
Lenov who was with me every step of the way and without whom graduate school would have 
been a much lonelier experience. 
I’d like to thank others at the University of Illinois for their help, Dr. Dean Olson for his patient 
training at the NMR facility, Dr. Kevin Tucker for his expertise at TLC-MS, and Prof. Ryan 
Bailey for all his guidance.  I also thank Prof. Tom Meade and Christiane Carney at 
Northwestern University for the exciting opportunity to collaborate on gadolinium chelate 
experimentation.  My sincerest thanks to Drs. Dan and Lisa Burden, my advisors at Wheaton 
College, who first gave me the opportunity to do research and whose guidance and support over 
the years has meant the world to me. 
Thank you to my friends and family for their ongoing support.  From encouragement to 
providing distractions, from challenging me to being on the same wavelength, you have made 
living in Champaign-Urbana the joy I never imagined it could be.  Finally, I’d like to thank my 
parents for their advice, prayers and confidence in me which have bolstered me all these years 
and without whom I’d have never made it this far.  Thank you.  
  
 iv 
 
Table of Contents 
 
 
Chapter 1: Introduction to Nanodiscs ............................................................................................. 1 
 
Chapter 2: Lipid Exchange Between Nanodiscs ........................................................................... 19 
 
Chapter 3: Incorporation of Gadolinium Chelates into Nanodiscs ............................................... 33 
 
Chapter 4: Soluble Membrane Protein Libraries .......................................................................... 43 
 
References ..................................................................................................................................... 50 
 
  
 1 
Copyright © 2014 From Liposomes, Lipid Bilayers and Model Membranes: From Basic Research to Application 
Edited by Mu-Ping Nieh. Reproduced by permission of Taylor and Francis Group, LLC, a division of Informa plc. 
 
Chapter 1: Introduction to Nanodiscs 
 
1.1: The Need for Nanodiscs 
A large fraction of biological activity, from transport to signaling, takes place at the interface 
between cells and their surroundings.  In particular, the cell membrane hosts a large number of 
proteins that are responsible for this physiological activity. These proteins are major drug targets 
and have been the focus of extensive research over the years.  Typically they have hydrophilic 
domains that reside in the aqueous environment within or outside a cell, as well as hydrophobic 
regions within the bilayer that anchor them to the cell membrane but also make them difficult to 
express and purify. Methods effective for aqueous soluble proteins often result in aggregation 
and denaturation when applied to those that reside within the membrane.  This difficulty has 
resulted in the development of various membrane mimetic techniques that strive to incorporate 
membrane proteins into lipid environments in order to maintain the folding and function of the 
target protein while still producing a robust and simple system. 
The nanoscale membrane mimetics (called “Nanodiscs”) discussed in this chapter are effective 
for such efforts because they are composed of small discs of lipid bilayer (~10 nm in diameter) 
stabilized and rendered aqueous soluble by an amphipathic protein around the outer edge of the 
hydrophobic acyl chains (see Figure 1.1 for illustration). Nanodiscs are water soluble, small 
enough to contain a protein in its monomeric form, provide a native-like environment for the 
protein and are stable and easy to produce. Additionally, as discs, they are accessible from both 
sides without a closed interior. Nanodiscs have proven to be an excellent membrane mimetic and 
solution to the difficulties of working with membrane proteins. The development of 
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Nanodiscs, the approach by which they are made and examples of the types of proteins and 
techniques that have found success are described in this chapter. 
 
1.2 The Development of Nanodiscs 
The concept of Nanodiscs originated with the high-density lipoproteins (HDL) that are 
responsible for the transportation of cholesterol through the bloodstream. HDL is primarily made 
up of phosphatidylcholine (PC) lipids, cholesteryl esters and apolipoprotein A-I (apoA-I), a 
flexible, amphipathic protein made up primarily of helices that help stabilize the HDL structure. 
Recently formed and lipidated HDL is devoid of cholesteryl esters and is roughly discoidal in 
shape. As the cholesteryl esters are added to the HDL core, the particle becomes spherical.
1
 
Recombinant HDL (rHDL) can be formed in vitro through the combination of lipids and 
apolipoproteins.
2
 HDL and rHDL have been the focus of extensive research but the heterogeneity 
of the resulting particles makes them nonideal for membrane mimetic applications in which 
monodispersity and homogeneity are key.    
In order to address these concerns, the membrane scaffold protein MSP1 was engineered based 
on apoA-1 with 43 N-terminal residues removed.
3
 Further systematic N-terminal truncations 
from the original MSP1 sequence revealed which portions are required for assembly of 
monodisperse Nanodiscs with high yield, and an optimized sequence of MSP1D1 was derived 
and characterized.
4
 To aid in the purification and utility of MSP, epitope tags and cleavage sites 
were incorporated. MSP has been produced with hexa-histidine or FLAG tags as well as TEV or 
Factor X cleavage recognition sites.
3-5
 In order to further increase the utility of Nanodiscs, longer 
MSPs were created by the addition of one or more 22-mer amphipathic helices to the protein.
4,5
  
Since the encircling membrane scaffold proteins determine the size of the resulting discoidal 
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lipoprotein particle at optimum lipid loading, the longer MSPs assemble to larger Nanodiscs. 
Larger lipoprotein particles can accommodate larger membrane proteins, oligomers, or complex 
assemblies for study. The two commonly used types of MSP are MSP1D1 and MSP1E3.  
MSP1D1 excludes an additional 11 residues from the MSP1 sequence that do not participate in 
Nanodisc formation and includes a hexa-histidine tag and TEV recognition site.  MSP1E3 
includes three additional helices to the middle of the sequence, as well as the affinity and 
cleavage tags.
5
 Different lipids (and mixtures of lipids) can comprise the lipid bilayer within 
Nanodiscs and, along with the variations of MSP available, makes Nanodiscs a flexible system 
and useful in a wide variety of biochemical systems and analytical applications.
6-9
  
The Nanodiscs themselves are created by self-assembly; the organization of the components into 
the discoidal shape minimizes the interaction of hydrophobic domains of the lipids and MSP 
with the aqueous environment.  A bilayer arrangement of lipids is formed so the hydrophilic 
head groups face outward and the hydrophobic tails are inside, away from the water.  The 
boundaries of this bilayer structure are stabilized by the MSP, which wraps around the perimeter 
of the disc and shields the hydrophobic portions from the solvent. In this way, the overall 
Nanodisc is hydrophilic and soluble in water, while including an environment suitable to house 
the hydrophobic domains of membrane proteins.
4,6,10
   
 
1.3 Preparing Nanodiscs 
Nanodiscs are formed by self-assembly from a reconstitution mixture which is comprised of 
lipids, MSP, detergent and the target membrane to be incorporated, if applicable (illustrated in 
Figure 1.2).The most important factors for the optimal assembly of membrane proteins into 
Nanodiscs include the lipid-protein stoichiometry and the careful choice of detergent and 
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temperature.   An optimal lipid-protein stoichiometric ratio can be estimated based on geometric 
considerations, as has been described.
4,6,11
  The average number of lipids per Nanodisc reflects 
the mean surface area per lipid molecule (0.67 – 0.70 nm2 for POPC at ambient conditions) and 
the diameter of Nanodisc, which is in turn determined by the length of the corresponding 
scaffold proteins.  Choice of lipid, or a mixture of lipids, may be dictated by the specific goals of 
experiments (lipid charge, chemical structure, or composition of lipid mixture). When natural 
membranes are used,
12,13
 the self-assembly mixture can be doped with extra lipid to optimize the 
lipid-protein stoichiometric ratio during the assembly to provide a better yield. 
The best detergents for Nanodisc self-assembly are those with high critical micelle 
concentrations (CMC), which can be easily dialyzed or removed from solution by adsorption to 
Biobeads.
6
 The ability of the detergent to solubilize lipids and target protein in an optically clear 
micellar solution is important. Cholate is good for lipid solubilization at a molar ratio of 2:1 or 
higher (and absolute concentration near CMC or higher), but not all membrane proteins are 
amenable to cholate solubilization. In this case mixed detergent systems can be used, where 
cholate is used for initial solubilization of lipids and MSP, and other detergents (alkyl maltoside 
or glucoside, polyoxyethylene glycols, phosphocholines, CHAPS, etc.) are used for the target 
protein.  
Temperature is also an important parameter for successful incorporation of membrane proteins 
into Nanodiscs. Multiple experiments have revealed that the best results and highest yield can be 
achieved by performing the self-assembly process and detergent removal near the temperature of 
the main phase transition of the corresponding lipid bilayer, which is 270K for 1-palmitoyl-2-
oleoyl-sn-glycero-3-phosphocholine (POPC) and 297K for 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC).  
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The formation of homogeneous discs is dependent upon the proper ratio of lipids to MSP, and 
hence lipid concentration should be measured precisely in the reconstitution mixture. The stock 
solution of lipid is quantified by phosphate analysis. The solvent is then dried from the lipids in a 
test tube using a stream of nitrogen gas while rotating the tube such that the lipids form a thin, 
even coating around the sides and bottom.  The avoidance of a large clump of dried lipid at the 
bottom of the test tube will aid in the ensuing detergent solubilization process.  The test tube is 
then put under vacuum overnight to remove any remnant solvent.  A 0.1M solution of cholate is 
added to the dried lipids in a hot water bath, and vortexing and sonication are used to solubilize 
the lipids so that no visible film or particles remain.  A ratio of 2:1 cholate to lipid should be 
used to ensure adequate solubilization.  To this mixture MSP in its aqueous buffer is added 
according to the optimal ratio based on the lipids used and the size of the MSP (see Table 1.1).  
The mixture is allowed to incubate for at least 15 minutes at a temperature above the lipids’ 
transition temperature. 
If membrane proteins are to be incorporated into the Nanodiscs, they must first also be detergent 
solubilized.  The optimal detergent and protein concentrations are not generic and must be 
determined for each protein individually.  The solubilized protein is added to the disc 
reconstitution mixture at low ratio (e.g.1:20) compared to MSP.  Two MSPs are necessary to 
form each Nanodisc and an excess of discs increases the probability that the membrane proteins 
will be incorporated monomerically. However, this ratio is dependent on the goals of the study. 
If oligomerization is desired, the ratio may be varied.  
At this stage everything is solubilized, but Nanodiscs have not yet formed; in order for the self-
assembly to occur, the detergents must be removed.  This causes the components to rearrange 
themselves to minimize the interactions of the hydrophobic domains with the aqueous solvent.  
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Dialysis or polystyrene beads, such as Biobeads, can be used to remove the detergents from the 
reconstitution mixture.  The beads are added to the mixture and allowed to incubate with shaking 
for several hours and then are separated from the mixture by filtration or centrifugation. The 
removed beads should be washed with buffer to remove any disc components that may have 
remained at the bead surface to ensure maximal yield of Nanodisc formation.   
In order to separate the Nanodiscs from any excess components that may have not been properly 
incorporated and to ensure the homogeneity of the Nanodiscs, the mixture is fractionated using 
size exclusion chromatography (SEC). Protein standards with known Stokes diameters such as 
bovine thyroid thyroglobulin (17 nm), horse spleen ferritin (12.2 nm), bovine liver catalase (10.4 
nm) and bovine serum albumin (7.1 nm) are used to calibrate the column.  Bare Nanodiscs using 
MSP1D1 should elute at about the same time as catalase.
3-5
 
As mentioned earlier, to achieve homogeneous disc populations, optimal lipid-protein ratios are 
necessary.  This ratio is dependent upon both the MSP length and the lipid to be incorporated.  If 
insufficient amount of lipid is used, heterogeneous particles are formed and free MSP is present.  
Alternatively, having excess lipids above the optimal ratio yields a broadened size distribution 
and aggregates of unincorporated lipids.
3,4
 The optimal ratio for selected lipids are presented in 
Table 1.1;
6
 for other lipids, the ratio can be estimated by calculating the number of lipids that 
would fit into the area of the Nanodisc based on the mean surface area per lipid.
4,5
 Analysis by 
SEC should show one narrow peak with minimal shouldering or additional aggregates (Figure 
1.3). 
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1.4 Understanding and Characterizing Nanodiscs 
A variety of different techniques have confirmed the basic structure and dimensions of 
Nanodiscs. Scintillation counting of tritiated lipids determined the average number of lipids per 
Nanodisc, which remained consistent across an SEC elution profile,
4
 indicating that the ratio 
between lipids and MSP is consistent and reproducible at constant lipid and MSP ratios. As 
mentioned earlier, the size of the Nanodisc is largely dictated by the length of the MSP, and 
therefore about the same number of lipids will be present in Nanodiscs made with the same 
components.
4
  
The diameters of the Nanodiscs were determined by SEC using standard proteins to create a 
calibration curve.  Accordingly, the Nanodiscs formed with MSP1D1were estimated to have a 
Stokes diameter of ~9.7nm.
3,4
  Initial size estimates were also made by scanning probe 
microscopy (SPM) performed on Nanodiscs adhered in a single layer to atomically flat mica, 
which suggested a width of ~10 nm and a height equivalent to the thickness of a single lipid 
bilayer (5.5 nm)
3
. Small-angle x-ray scattering (SAXS) further confirmed a diameter of ~10 nm, 
as well as the discoidal shape of the particles.
4,14
  More recent SAXS and neutron scattering data 
at different lipid:MSP ratios suggest an elongated oval disc, although it appears that the 
preparation used in these studies was underlipidated.
15
 
Further insight into Nanodisc structure has been revealed by molecular dynamics (MD)
1617-20
. In 
the first study,
16
 four different all-atom simulations were run: Three that varied the length of the 
MSP and one in which the alignment of the MSPs relative to each other around the Nanodisc 
was changed.  The experimentally determined number, 160 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC) molecules per Nanodisc
4
, was used for each of the simulations. 
Simulations of MSP1D1 with the first 11 N-terminal residues are removed formed stable discs. 
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The scaffold protein with 22 N-terminal residues removed had worse vertical alignment of the 
MSPs and indicated that too many residues may have been deleted.  In contrast, Nanodiscs 
formed with the original MSP1 sequence with no truncations were distorted due to an 
insufficient number of lipids to fill out the belt. This result indicates that not all of the residues in 
the MSP sequence are necessary for the belt stabilization of the Nanodiscs, confirming what had 
been experimentally determined through sequence deletions.
4
  It was also determined that it is 
unlikely that the Nanodiscs form with the MSP gaps aligned because such a simulation yielded a 
distorted disc,
16
 although the optimal mutual orientation of the belts could not be determined de 
novo. 
Early on there were several different hypotheses regarding the configuration of the amphipathic 
protein around the phospholipids, amongst them are the picket fence
21 and the double belt 
configurations.
14
  Results obtained using polarized internal reflection infrared spectroscopy 
indicated that the two proteins encircled the lipids about the perimeter in accordance with the 
belt configuration.
22
 This model was confirmed by magic-angle spinning solid-state NMR 
wherein the arrangement of the prolines in the MSP sequence correlate to what would be 
expected for the double belt model, but not that of the picket fence.
23
 The results of these 
independent experiments have built confidence in a model of Nanodiscs as circular portions of 
lipid bilayer with MSP encircling in the double belt conformation. 
 
1.5 Membrane Proteins in Nanodiscs 
The functional properties of membrane proteins can be evaluated through their assembly into 
Nanodiscs. Several eukaryotic cytochromes P450 have been successfully studied using 
Nanodiscs.
24
 Detailed biophysical and biochemical characterizations of the stable monomeric 
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human cytochrome P450(CYP) 3A4  in a phospholipid bilayer was possible with its 
incorporation into Nanodiscs.
25-27
 These experiments revealed the full spin-state conversion upon 
substrate binding (e.g. with bromocriptine and testosterone), fast oxygen binding and 
autoxidation, and significantly higher stability with respect to formation of the inactive P420 
form.  Co-incorporation of CYP3A4 and NADPH-cytochrome P450 reductase (CPR) in 
Nanodiscs made possible the global analysis of the steady-state kinetics and resulted in 
deconvolution of the stepwise binding constants and fractional contributions of binding 
intermediates to the overall NADPH consumption and product formation.
28,29,30
 The successful 
co-incorporation of CYP73A5 and NADPH P450 reductase into Nanodiscs outlined the general 
approaches to the high-throughput screening of multiple eukaryotic cytochromes P450 expressed 
in baculosomes.
13
  
Later it was shown that simple addition of full length CPR to CYP3A4-Nanodiscsresultsin facile 
incorporation of reductase into Nanodiscs and formation of functionally active complexes.
11
 
Equilibration of the system takes only 5 – 10 minutes at 37 °C as monitored by the rate of 
steady-state NADPH consumption. This approach is fast and straightforward and provides an 
opportunity for development of quick and efficient protocols for in vitro screening of 
mammalian cytochromes P450, especially when the availability of purified P450 isozyme is a 
limiting factor.   The same approach can be easily extended to other membrane bound enzymes 
that require redox partners.  
Several integral membrane proteins such as G protein-coupled receptors (GPCR), channels, and 
transporters have been incorporated in Nanodiscs in monomeric form for structural and 
functional studies.
31-34
  Predominantly monomeric states of target proteins in Nanodiscs are 
easily achieved by using large molar excess of lipid and scaffold protein to facilitate “dilution” 
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of oligomers and favor monomerization.
6
 This protocol was first developed using 
bacteriorhodopsin from Halobacteriumsalinarum
12 
and later used for beta-2 adrenogenic 
receptor,
35
 rhodopsin,
31,32,36
  proteorhodopsin,
37
 and other receptors.
38,39
 These studies provided 
for the first time a stable system to address directly the physico-chemical and functional 
properties of monomeric proteins which normally exist in dimers or oligomers in vivo. 
Deciphering the role of supra-molecular organization of these oligomeric receptors is critically 
important for mechanistic understanding cell signaling processes as well as for development of 
new drugs targeting GPCRs.
40
 This goal cannot be achieved without deconvolution of the 
functional properties of monomers and the role of membrane structure and composition in 
oligomer formation and function. For these studies Nanodiscs represent an ideal system that is 
being used currently in many studies of integral membrane proteins.
41-45
  Complex biological 
machines found in membranes can also be assembled into Nanodisc, for example, light-
harvesting complex II (LHCII) has both fluorescent and quenched conformations which are 
sensitive to aggregation which alters the fluorescence signal.  LHCII trimers were incorporated 
into larger Nanodiscs (utilizing the longer scaffold protein) and the absorbance and fluorescence 
spectra indicated that the complex was properly folded and functional within these Nanodiscs 
without the formation of larger aggregates.
46
 Similarly, chemoreceptors exist as homodimers, but 
further oligomerization of these dimers occurs.  With controlled stoichiometry Nanodiscs 
containing different numbers of dimers were formed and their activities were tested.
47
  The 
functions of ligand binding, adaptational modification and trans-membrane signaling could be 
accomplished by a single dimer of chemoreceptor, however, activation of chemotaxishistidine 
kinase required the higher order interaction of three dimers. In previous membrane mimetic 
techniques, such as vesicles, the number of chemoreceptors could not be controlled but through 
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Nanodiscs the functionality of the different forms could be determined.
47,48
  Similarly, Nanodiscs 
were used to characterize the clusters of histidine kinase CheA, coupling protein CheW and 
chemoreceptor Tar suggesting that the core unit of the signaling complex consists of  2(Tar2)3: 2 
CheW: 1 CheA2. 
48,49
 
Protein translocation across a cell membrane was studied in Nanodiscs and was found to be 
accomplished through an assembly of three membrane proteins, SecY, SecE and SecG.  This 
assembly has been difficult to study ex vivo due to the difficulty in controlling oligomeric states 
in lipid vesicles.
50
  Previous studies led to conflicting results regarding the subunits necessary to 
accomplish the different tasks of the assembly.   By utilizing Nanodiscs, various roles of the 
proteins could be differentiated.  Although SecY can bind the preprotein, a dimer of SecY is 
necessary for transport.
41
  Similar techniques were used for rhodopsin, another membrane protein 
for which it had been unclear if a dimer is necessary for function. Monomeric rhodopsin was 
incorporated into Nanodiscs and it was found that a dimer is unnecessary for the phosphorylation 
by rhodopsin kinase (GRK1).
32,33,36
 
The structure of Nanodiscs also facilitates the study of some membrane proteins due to the 
Nanodiscs’ lack of an interior and exterior.  For this reason, liposomes and detergent micelles 
had been ineffective for studying the four-helix bundle HAMP domain switches responsible for 
transmitting signals from receptors to output domains.
51
 In Nanodiscs the incorporated proteins 
are accessible from both sides of the bilayer which allowed the different domains to be labeled 
and their accessibility and conformation to be determined through Förster resonance energy 
transfer (FRET)and electron paramagnetic resonance (EPR) spectroscopy which had been 
precluded by previous membrane methods.
51
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The F0F1-ATP synthase is a large, trans-membrane complex that transports protons across the 
cell membrane in the synthesis of ATP.  Incorporating F0F1 ATP synthase into Nanodiscs has 
allowed the mechanism of transport to be elucidated for this large molecular motor.  The 
complex could transport a proton across the Nanodisc bilayer and mutations to the proteins 
helped elucidate the mechanism by which this translocation occurs.
42
 
Nanodiscs with photosynthetic reaction centers were used in conjunction with carbon nanotubes.  
The Nanodiscs aligned along the carbon nanotubes and formed a complex that disassembles in 
the presence of detergents but reassembles back into a functional complex at the removal of the 
detergent which mimics the natural self-repair process.
52
 
Voltage-dependent anion channel (VDAC) regulates exchange between cytosol and the 
mitochondria, particularly of metabolites and ions.  The complex includes a β-barrel made up of 
19 trans-membrane strands.  After incorporation into Nanodiscs, solution NMR was carried out 
to identify the sites of nicotinamide adenine dinucleotide (NADH) binding and other structural 
features.
45
 
The effect of lipid environment on the photophysics of green proteorhodopsin was determined 
through variation of Nanodisc lipids.
37
  Similarly, the head groups of surrounding lipids was 
found to control the blood clotting cascade.
53
  Thus, a wide variety of membrane proteins have 
been successfully incorporated into Nanodiscs and the resulting studies have demonstrated 
significant insight into their functional behavior. 
 
1.6 Analytical Techniques 
Nanodiscs have also opened up a number of analytical and biophysical techniques previously 
unavailable to the study of insoluble proteins. Membrane proteins have been difficult to study 
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through mass spectrometry (MS) because the detergents that aid in the solubilization of the 
proteins interfere with the resulting spectra.  MS is, however, a valuable proteomic technique.  
While Nanodiscs alleviate the solubility and detergent problems, the conventional sample 
preparation technique produces MALDI-TOF spectra with prevalent MSP peaks that overwhelm 
those of the target membrane protein.  An ultra-thin layer method, however, was found to 
remove a significant portion of the MSP so that a clear signal can be obtained for the protein 
target.
54
 Through this methodology, mass spectrometry is available to Nanodisc encapsulated 
membrane proteins.  
The structure of integral membrane proteins is difficult to acquire from crystallography or NMR 
due to the combination of their size and tendency to aggregate rather than form crystals.  
Hydrogen exchange coupled with mass spectrometry can provide information about the structure 
of the membrane proteins despite the previously mentioned difficulties. The amide hydrogens in 
the peptide backbone are able to exchange with the surrounding solvent. A deuterated solvent 
exchanges deuterium into the protein backbone and this additional mass can be detected by MS.  
The protein is then digested and the segments with additional mass indicate which residues are in 
contact with the solvent or are present in an area of the protein structured against solvent contact.  
While this method gives less detailed information than x-ray crystallography, some preliminary 
structural information can be determined through hydrogen exchange.  Engen et al. has 
performed this technique both on MSP itself and the membrane protein γ-glutamyl carboxylase 
(GGCX) within Nanodiscs.
55,56
  The MSP was confirmed to have a different structure between 
its free and Nanodisc conformations, and a predicted topology map was created for GGCX 
according to the structural information determined by hydrogen exchange. 
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Surface studies and imaging of Nanodiscs and their incorporated proteins can be accomplished 
through atomic force microscopy (AFM), where cations induce Nanodiscs to lie flat, in a single 
layer, along the mica or silicon oxide surfaces.
57,58
  This is key to being able to faithfully image 
the discs and proteins and get an accurate measure of their heights. In this way, when imaged 
using AFM, the thickness of the discs above the mica is indicative of a single Nanodisc layer 
oriented such that the acyl chains of the lipids are perpendicular to the mica surface and the 
bilayer of the Nanodisc runs parallel.
58  
NADPH-cytochrome P450 reductase and cytochrome P450 2B4 (CYP2B4) are examples of 
proteins that were studied through incorporation in rHDL particles which were laid down on 
mica and studied with atomic force microscopy. Peaks above the rHDL surface along with 
activity measurements indicated the successful insertion of active P450 reductase into the rHDL 
bilayer
57
 and atomic force microscopy of CYP2B4 showed similar peaks 3.5nm above the rHDL 
surface.
59
 CPR contains a trypsin cleavage site between the catalyst domain and the membrane 
anchor and the rHDL containing CPR protrusions were reimaged after treatment with trypsin. 
The resulting images show that the majority of the peaks had been cut away, evidence that the 
P450 reductase was responsible for the height variation.
57
 Nanodiscs provide a convenient 
manner in which the surface analysis of membrane proteins can be achieved and characterized. 
Nanodiscs are useful for other analytical techniques such as surface Plasmon resonance (SPR) 
because the encircling MSP prevents lateral diffusion and aggregation of the proteins as well as 
denaturation or “poisoning” of the surface.  This is a key difference between Nanodiscs and other 
membrane capture methods, such as vesicles, in which this diffusion and resulting aggregation is 
a concern.  Borch et al. used cholera toxin subunit B (CTB) and glycolipid receptor GM1 to test 
the effectiveness of SPR on a Biacore system.
60
 They found that chips coated with antibodies, 
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particularly the anti-tetra-His, were effective for immobilizing Nanodiscs tagged with hexa-
histidine to the flow cells.  Nanodiscs containing GM1 were immobilized in the sample flow cell 
and in order to account for nonspecific binding empty discs were immobilized in the reference 
flow cell.  When the solution containing CTB was flowed over the cells, the response increased 
in the sample cell, implying that CTB had bound to the GM1. Binding through the tetra-his 
antibody prevented leakage from the sensor-chip, indicating that the Nanodiscs remained 
immobilized in the cells over the course of the experiment.
60
  
SPR, however, is only useful for the binding of large molecules that cause a significant change in 
the bulk refractive index. Localized surface Plasmon resonance (LSPR) can be used to detect the 
binding of small drug molecules to a protein.  A common drug target, CYP3A4, was 
incorporated into Nanodiscs and drug binding measured through the coupling of the electronic 
transitions of the target protein with the surface plasmon. This technique was shown to be of use 
in large-scale screening of potential drugs to P450 proteins.
61,62
  
Other structural methods, such as solution and solid state NMR,
63-66
 have successfully been 
adapted for working with Nanodiscs.  The variety of techniques available allows a wide range of 
information to be gathered about membrane proteins. 
 
1.7 Conclusion 
Only a few examples of the utilization and application of Nanodiscs have been presented here. 
Nanodiscs have found wide application in biophysical studies with a large variety of proteins and 
analytical techniques. Several review articles describing the Nanodisc technology have been 
published.
6-9,24
  Nanodiscs represent an efficient tool for resolving a number of biochemical 
questions; their ease to both create and manipulate, as well as their dependability and 
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reproducibility, have allowed and stimulated significant progress in the field of membrane 
protein biochemistry.  When once many of those areas were closed due to their experimental 
difficulty, the addition of Nanodisc technology to the toolbox of biochemists permits the 
exploration of previously excluded areas of study. Described herein are experiments analyzing 
the exchange of lipids from Nanodisc bilayers from one disc to another over time, the inclusion 
of gadolinium chelates for use as MRI contrast agents and the transfer of proteins from native 
membranes into Nanodiscs to form protein libraries. 
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1.8 Figures and Tables 
 
Figure 1.1 An illustration of the Nanodisc, composed of a portion of lipid bilayer whose outer 
acyl chains are surrounded by two amphipathic Membrane Scaffold Proteins (MSP). 
 
 
 
 
Figure 1.2 Depiction of the Nanodisc formation process. (A) MSP and detergent solubilized 
lipids, (B) the removal of detergent, (C) fractionation and purification through SEC to produce a 
(D) fully formed Nanodisc. 
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Table 1.1 Reconstitution ratios and temperatures for the formation of Nanodiscs for three 
commonly used lipids.
6
 
 Optimal ratios for 
MSP1D1:lipid 
Optimal ratios for 
MSP1E3:lipid 
Incubation 
temperature 
DPPC 90:1 170:1 37 ºC 
DMPC 80:1 150:1 25 ºC 
POPC 65:1 130:1 4 ºC 
 
 
 
Figure 1.3 An example of a size exclusion chromatograph of Nanodiscs on a calibrated column. 
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Chapter 2: Lipid Exchange Between Nanodiscs 
 
2.1 Radiolabeled Lipids 
Since Nanodiscs are non-covalent lipid bilayer complexes that self-assemble in order to 
sequester the hydrophobic portions of the complex away from aqueous solvent, the lipids that 
make up the bilayer of the complex are not covalently bound to the Nanodisc structure and are 
free exchange between Nanodiscs. 
Some membrane proteins require a particular lipid head group or that the bilayer have a certain 
ionic charge in order for binding to occur.
67
  In order to accommodate this, Nanodiscs with many 
different lipid compositions can be created.  Of particular interest are Nanodiscs doped with1-
palmitoyl-2-oleoyl-sn-glycero-3-phospho-L-serine (POPS) amidst 1-palmitoyl-2-oleoyl-sn-
glycero-3-phosphocholine (POPC).  At neutral pH POPC is zwitterionic and POPS is negatively 
charged, therefore mixed POPC and POPS bilayers will have a negative charge overall. The 
working assumption is that if 20% of the lipids used in the Nanodisc reconstitution mixture are 
POPS, those POPS molecules will evenly distribute between the resulting Nanodiscs and will 
remain evenly distributed over time. 
Previous work demonstrates that lipids exchange between discs over time (Figure 2.1).  Initial 
studies analyzing the exchange of tritium-labeled POPC lipids between Nanodiscs demonstrate 
lipid exchange over the course of hours.  In the experiment, two sets of Nanodiscs were made 
and incubated together; the first contained POPC with a fraction of the lipids tritium-labeled and 
the scaffold protein surrounding the Nanodiscs unlabeled.  The second population of discs 
included a poly-histidine tag on the MSP but no radiolabeled lipids. 
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At time points over the course of 100 hours, aliquots of Nanodiscs were taken and run through a 
nickel nitriloacetic acid (Ni-NTA) column to separate the discs that contained a his-tag from 
those that did not.  The column was washed and the Nanodiscs that flowed through were those 
that initially contained the tritiated lipids.  An imidazole containing buffer was run through the 
column and the eluted Nanodiscs were those from the second population that initially contained 
no radioactivity.  Scintillation counting was performed on both the flow through and the elutions 
to determine the number of radioactive counts present in each fraction.  The results clearly 
showed that lipids were exchanging between discs.  Figure 2.2 shows Nanodiscs that initially 
contained no radioactive counts gain nearly half of the total counts after 100 hours. 
For a purely POPC system, this technique was effective but it does not lend itself well to mixed 
POPC-POPS systems because radiolabeled POPS cannot be readily acquired. Additionally, the 
loss of total radioactive counts during the process was of concern; therefore, other techniques 
were considered in order to further address the question of lipid exchange. 
 
2.2 Imaging Proximity Assay 
Imaging proximity beads are polystyrene beads that are coated in an affinity tag, such as 
streptavidin.  Similar to the scintillation counting method, one set of Nanodiscs would contain 
radiolabeled lipids and a biotin tag while the other set had neither, and the two sets would be 
incubated together.  At time points over 100 hours, an aliquot of sample would be removed and 
added to the imaging proximity beads.  When the biotin from the Nanodiscs attached to the 
streptavidin of the bead, the bead becomes close enough to be hit by the radiation emitted from 
the lipids.  When this occurs, the bead emits light at 615 nm that can be detected by a CCD 
imager for quantitation. Figure 2.3 demonstrates this process. Over the course of time, as 
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radioactive lipids exchange into Nanodiscs lacking the biotin tag, the signal from the beads 
would decrease because the untagged discs do not bind to the bead surface and therefore are not 
close enough to cause the emission of light.  This method does not require a separation step, and 
would overcome the loss of scintillation counts that occurred in the previous method. 
Several chemical methods were used to biotinylate the MSP.  The first utilized N-
hydroxysuccinimide (NHS) to react with the N-terminus of the protein.  The results were 
analyzed with a mass spectrometer and the resulting spectrum showed that there was a mixture 
of unlabeled, singly labeled and doubly labeled proteins present in the sample.  The NHS 
reactive group can also react with lysines present in the protein, which leads to this inconsistent 
labeling. 
The procedure was repeated, this time the incubation was done at both room temperature and 
37°C.  The sample incubated the in warmer temperature contained less unlabeled MSP than that 
at room temperature, but also contained high amounts of doubly and even triply labeled protein.  
This method of biotinylation was not well suited for the experiment because the binding of 
Nanodiscs to multiple beads would result in an increase in fluorescent signal that would interfere 
with the quantitation of the experiment. 
A variant of MSP had previously been made with an aspartic acid residue substituted with a 
cysteine, which can be used for maleimide labeling with biotin.  When the resulting protein was 
analyzed with MS (Figure 2.4), it did include non-labeled MSP but no multiply labeled protein 
was present.  This would avoid the problem of discs binding to multiple beads, however, still not 
all the discs that ought to have the tag would bind. 
This line of experimentation was abandoned, however, due to the prevailing unavailability of 
radiolabeled POPS. The method could be used to study Nanodisc samples of POPC or DMPC for 
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which radiolabeled species are available, but since the exchange of POPS in POPC bilayers is the 
system of interest, other techniques which could differentiate between the two were considered 
instead. 
 
2.3 Nuclear Magnetic Resonance 
A technique that can readily detect the difference between POPC and POPS is phosphorus NMR.  
31
P is the naturally abundant isotope of phosphorus and is NMR active.  NMR spectra of each 
lipid contain only the one peak corresponding to the phosphorus in the head group.  The shift of 
the peak is dependent upon the immediate environment surrounding the phosphorus atom, and 
the two head groups are adequately different to create different shifts.
68,69
  Therefore, in a 
mixture of POPC and POPS two peaks arise, one for each lipid (Figure 2.5).  Despite the ability 
to differentiate between the two in the NMR spectra, quantification remained a hurdle. 
Unlike in proton NMR, the area under the peaks in 
31
P NMR could not simply be integrated and 
used to determine the relative amount of each species.  However, to determine the significance of 
this effect, a calibration curve was created to compare concentration of POPC to the area beneath 
the peak. The results of the calibration curve (Figure 2.6) were correct within the order of 
magnitude, but the calculated concentrations contained errors up to 70% compared to the 
concentration used to produce the solution, which was inadequate for a quantitative experiment. 
Additionally, the sample requirements necessary to accumulate adequate signal were large.  Each 
NMR sample needed to have at least 500 µL of sample and lipid concentrations in the millimolar 
range.  In order to achieve this, each time-lapse experiment would require about 20 mg of MSP, 
so a technique requiring smaller samples was sought out. 
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2.4 Thin Layer Chromatography-Mass Spectrometry 
Matrix-assisted laser desorption/ionization mass spectrometry (MALDI-MS) was an attractive 
option for detection because only a few nanomoles of sample are required for each time point 
aliquot.  The difficulty with MALDI-MS is that the POPC and POPS ions have the same mass, 
so by itself MALDI-MS could not adequately differentiate between the two lipids.  However, if a 
separation step were included, then POPC and POPS could be analyzed individually.  
Additionally, POPC and POPS are not directly quantifiable because their levels of ionization by 
the MALDI process are not equivalent.  POPC is ionized much more readily and presents as a 
larger peak even when equivalent amounts of POPC and POPS are present in the original 
sample.
70
 In order to overcome this, versions of both lipids with one fatty acid chain deuterated 
were purchased in order to be spiked into the lipid sample as internal standards.  This way, the 
amount of deuterated POPS (d-POPS) can precisely be known and since POPS and d-POPS react 
the same way to the ionization process; the resulting peaks in the spectra can be integrated and 
summed for both the deuterated and undeuterated versions.  The ratio of the sum of the d-POPS 
peaks to the sum of the POPS peaks is equal to the molar ratio (Figure 2.7).  Therefore, if the 
number of moles of d-POPS in the sample is known, the number of moles of POPS can be 
calculated.  The same can be done for POPC based on the deuterated version (d-POPC).  
Through these calculations the ratio of POPC and POPS in each sample can be determined. 
Additionally, different voltage polarities are required for the optimal detection of POPC and 
POPS.  POPC is well ionized in positive mode, while POPS is better detected in negative mode.  
Fortunately, the reversal of polarity can easily be done during the course of the experiment and 
creates very little further complication.   
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As previously mentioned, a separation technique is required in order to properly differentiate 
between POPC and POPS. Liquid chromatography mass spectrometry (LC-MS) is frequently 
used for lipid analysis.
71
  Reverse-phase chromatography is used for tail group separation while 
normal phase is used for head group separation.  Since the two lipids of interest have the same 
tail group, normal phase chromatography was necessary to separate the lipids.  However, the 
liquid chromatography instrument adjoined to the mass spectrometer was not available for 
normal phase separations.  
Schiller et al. published a method utilizing thin layer chromatography (TLC) in order to perform 
lipid separations with MALDI-MS analysis.
72
  A mobile phase of 35:35:7:35 chloroform: 
ethanol: water: triethylamine was utilized to separate hen egg yolk phospholipids.  The mixture 
of phospholipids did not include lipids with phosphatidyl serine (PS) head groups and so a 
different mobile phase was required to perform a separation between the PC and PS lipids.  
According to Avanti, separation of phosphatidyl choline (PC) and PS head groups can be 
achieved by using 65:25:4 chloroform: methanol: ammonium hydroxide.
73
 
This combination did successfully separate the two lipids, but triethylamine was substituted for 
the ammonium hydroxide in order to not introduce more salts to the sample, which can hinder 
MALDI-MS.  Directly substituting triethylamine for ammonium hydroxide continued to separate 
PC and PS and this mobile phase of 65:35:4 chloroform: methanol: triethylamine was utilized.  
After being put in an iodine chamber for visualization, combined solutions of POPC and POPS 
show separation, confirming that head group separation was achieved. Samples with a 
combination of each lipid with its deuterated counterpart showed only one spot, confirming that 
the two co-migrate and that the additional mass from the deuterium does not interfere. Samples 
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that contained all four species displayed two spots as well, one for each head group.  Figure 2.8 
demonstrates all of these scenarios. 
Mass spectrometry of pure PC and PS with their corresponding deuterated versions showed 
peaks at their exact masses, along with sodium adducts and a distribution of peaks at the mass 
range of the deuterated standards (Figure 2.9).  The ratio of the sum of the non-deuterated peaks 
to the sum of the deuterated peaks was compared to the molar ratio.  The calibration curve does 
show that the ratio of the sum of the peaks is nearly equivalent to the molar ratio (Figure 2.7).  
In order to determine the exchange of lipids over time, two populations of Nanodiscs were 
created.  The first contained both POPC and POPS in equivalent molar amounts and MSP with a 
his-tag so these discs would adhere to the nickel affinity column.  The second set of Nanodiscs 
contained neither a his-tag nor POPS and these Nanodiscs should wash through the column.  
Over the course of time, the amount of POPS in the Nanodiscs eluted from the column would 
decrease as the lipids transfer to the Nanodiscs without the his-tag. Equal molar amounts of each 
type of Nanodisc were combined and briefly shaken.  One tenth of the volume was removed, 
added to the nickel column and a wash buffer (20 mom Tris, 100 mM NaCl, 15mM imidazole) 
was run through, followed by an elution buffer(20 mM Tris, 100 mM NaCl and 500 mM) 
imidazole. Both the flow-through and the elution fractions were collected. 
After the first aliquot was added to the column, the remaining sample was stored at 4 °C with 
constant shaking. At time points over the course of 100 hours, aliquots were removed and 
separated on the nickel column while the remainder continued to be shaken at 4°C.  
When all of the aliquots had been removed the collected eluents were concentrated to between 
10-20 µM and volumes of approximately 50 µL. A solution of deuterated standards of both 
POPC and POPS solubilized in cholate was created and added to the samples so that the ratio of 
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non-deuterated to deuterated lipids was 3:2. The lipids were extracted from the samples 
according to the Bligh-Dyer method
74
 using 1:2.5:1.25 aqueous sample: methanol: chloroform, 
vortexing the solution, then adding 1.25:1.25 chloroform and water.  The sample was vortexed 
again and then allowed to phase separate. The lipids were extracted into the denser chloroform 
layer, which was removed with a syringe. The volume of chloroform resulting from the 
extraction was too much to spot on a TLC plate, so the chloroform was evaporated and 5 µL of 
chloroform was added to the dried lipid to redissolve the sample.  The dissolved lipids were 
spotted on the TLC plate along with standard POPC and POPS and their deuterated versions 
included in adjacent lanes.  This lane of standards was included in order to show where each of 
the head-group spots ought to be if inadequate lipid had been loaded into the experimental lanes 
for the spots to be seen by eye.  Since MALDI-MS is much more sensitive than the iodine 
staining, it could still detect the lipids even if no iodine spot were visible, provided an estimation 
of the spot’s location could be determined. 
About 35 µg of lipid was loaded at a time in order to achieve spots that would be visible after the 
iodine staining but not so much as to cause streaking.  The plates were put in a chamber saturated 
with the mobile phase and when the solvent front neared the end of the plate, it was removed and 
allowed to dry.  The plate was then placed in the iodine chamber until an orange color coated the 
plate surface.  The iodine was allowed to sublimate off the surface and visible spots appeared 
and were marked.  Afterward, the plates were placed under vacuum for several days to remove 
any remaining solvent and iodine still held by the silica. 
Before mounting the TLC plates into the mass spectrometer, 2,5-dihydroxybenzoic acid (DHB), 
a MALDI matrix, was spotted over the marked areas on the plate and allowed to dry.  The plate 
was then inserted into the instrument for the spots to be analyzed.  A MALDI method 
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appropriate for the mass range of lipids was utilized and both positive and negative polarities 
were necessary in order to identify both POPC and POPS. 
When this experiment was run to completion, only one visible spot could be seen in each lane 
(Figure 2.10).  Based on its travel length down the plate, it was likely POPS.  Since POPC 
usually travels about a third as far, DHB was spotted along those regions of the lanes as well.  
However, when analyzed, both POPC and POPS were present on the plates, but the separation 
was incomplete and streaks of both occurred down the lanes.  This indicated that the TLC 
method and solvent conditions require further optimization in order to achieve more complete 
separation. The spots do not travel far compared to the solvent front, so decreasing the polarity of 
the mobile phase (by increasing the ratio of chloroform) may improve the separation.  The 
deuterated standards could barely be seen over the noise, so in future experiments, more standard 
should be spiked in. This could ameliorate both the signal to noise and the visibility of the spots. 
This TLC-MALDI MS method is promising for the quantification of the exchange of POPC and 
POPS in Nanodiscs.  It satisfies the requirements for small sample amounts and requires no rare 
materials.  Minor optimization is required, but the technique achieves the goals of the 
experiment. 
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2.5 Figures 
 
Figure 2.1 Two populations of Nanodiscs are combined; one that contains a mixture of lipids 
and another that contains only one type; over time both populations become mixed through lipid 
exchange between the discs.  
 
 
 
Figure 2.2 Radioactive counts over time shows the transfer of radiolabeled lipids from their 
initial Nanodiscs that had no affinity tag, and therefore washed through the column, into 
Nanodiscs that included a histidine tag and were eluted from the column with imidazole. Figure 
and data courtesy of Dr. Mark McLean. 
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Figure 2.3When the biotin on the Nanodiscs binds to the streptavidin coating on the beads, the 
radiolabeled lipids within the disc are close enough that the bead can absorb the radiation and 
emit light. When no binding has occurred, the emission from the lipids is absorbed by the 
surrounding water and no light is emitted. 
 
 
 
 
Figure 2.4Mass spectrometry analysis shows that after maleimide labeling, the majority of MSP 
contains one biotin tag, but that the labeling was incomplete and some MSP remains untagged. 
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Figure 2.5A mixture of POPC and POPS in 
31
P NMR produces only two peaks, one for the head 
group of each lipid. 
 
 
 
 
Figure 2.6A linear regression comparing the concentration of POPC in a solution with the 
integrated area beneath the resulting NMR peak. The results were linear, but produced large error 
when applied to mixed POPC-POPS samples. 
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Figure 2.7 The area of peaks from MALDI-MS is proportional to the concentration, so the ratio 
of the area of the peaks is equal to the mole ratio of deuterated to non-deuterated lipids.  This can 
be used for quantification if the amount of deuterated lipid (used as an internal standard) is 
known. 
 
 
 
 
Figure 2.8 TLC using chloroform, methanol and triethylamine 
for lipid separations. Lanes 1 and 6 contain solutions of pure 
POPC and POPS respectively.  Lanes 2 and 5 contain each lipid 
with its deuterated counterpart.  Lane 3 is a mixed solution of 
POPC and POPS and lane 4 is a mixture of all four lipids. This 
plate shows that PC and PS can be separated with this mobile 
phase and that the deuterated lipids co-migrate with their 
undeuterated counterparts. 
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Figure 2.9 Individual mass spectra of POPS and POPC with their deuterated  standards. The 
multiple peaks are present due to isotopes containing different numbers of deuterium. 
 
 
 
 
 
Figure 2.10 TLC separation of samples from 8 different time points. No clear separation 
occurred and spots were very faint from the iodine staining.
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Chapter 3: Incorporation of Gadolinium Chelates into Nanodiscs 
 
3.1 Background 
Magnetic resonance imaging (MRI) is a technique widely utilized in both clinical and research 
settings.  It relies upon an injected contrast agent to reduce the T1 relaxation time, the time it 
takes for the nuclear spin of the water molecules to realign with the magnetic field after being 
rotated by a radiofrequency pulse.  This reduction leads to a brightening in the image, creating 
contrast.
75
  The development of more effective contrast agents means that less material would 
need to be injected into a patient in order to achieve contrast suitable for visualization.  
Additionally, it would be desirable for some applications to develop contrast agents that remain 
in the body longer.  Contrast agents that are retained longer can be used for cell tracking or other 
longer scale experimentation. 
Gadolinium is used in these contrast agents for its ability to relax water.  However, Gd is toxic 
and must be chelated in order to safely be present in the body.
76
  The structure of these chelates 
can vary in order to optimize the suitability of the chelate for different applications. ‘C3lipo’ 
(Figure 3.1) was devised to include two hydrophobic chains with the intention that they would 
become anchored in cell membranes.  By anchoring there, the hypothesis is that they would stay 
in the cells longer and therefore create imaging contrast for a longer period of time.  The problem 
with this structure is that the hydrophobic tails render the chelate insoluble in aqueous solutions, 
making it difficult to work with and to incubate with cells. The hydrophobic groups of the 
chelate resemble the fatty acid chains of lipids so it was hypothesized that the chelate could be 
incorporated into Nanodiscs, which would render them soluble in aqueous solutions.  If the Gd 
chelate could be packed into discs, the Nanodiscs could be used as a delivery system to bring 
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payloads of chelate in contact with cell membranes for their uptake.  
 
3.2  Percentage Loading 
In order to maximize the contrast for in vivo studies, the loading of the Gd chelate should be 
maximized so that high inclusion of Gd can be introduced without needing to inject large 
amounts of sample.  Chelate loading was defined by the percentage of molecules in the bilayer 
region of the Nanodisc structure that were C3lipo instead of the 1,2-dimyristoyl-sn-glycero-3-
phosphocholine (DMPC).   DMPC was chosen to be the primary lipid in the Nanodiscs due to its 
higher transition temperature, which was hypothesized might help the chelate remain within the 
Nanodiscs. 
Loadings between 1 and 75 percent were attempted, with the focus of most experiments in the 15 
to 40 percent range.  At loadings over 40% the peaks from size exclusion chromatography (SEC) 
displayed shouldering or, in some instances, an entire additional peak.  Usually one of these 
double peaks occurs at the time typical for well-formed Nanodiscs, while the other comes off the 
size exclusion column later, meaning that the particles are smaller than their earlier counterparts.  
Above 30% C3lipo, peak broadening and some shouldering occurs, as shown in Figure 3.2.  The 
breadth of an SEC peak mirrors the extent of the size distribution, thus a narrow peak means less 
variation in size of the particles. The broader peaks in the preparation of Nanodiscs with C3lipo 
means the Nanodiscs do not all contain the same number of lipids or chelate.  In order to 
optimize the yield of monodisperse samples, subsequent loading was kept under 30% C3lipo.  
Additionally, when the concentrations of chelate were quantitatively measured after Nanodisc 
formation, it was confirmed that the chelate was not incorporated with ideal efficiency.  A 
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sample with the intended doping of 30% actually contained about 20% chelate after disc 
formation and purification. 
In order to not waste precious C3lipo sample, as synthesis and purification were difficult, doping 
over 30% were no longer pursued.  At 15% and below, SEC peaks more closely match those of 
pure DMPC Nanodiscs (Figure 3.3). 
 
3.3 Membrane Scaffold Proteins 
The absorbance of the amino acids that make up the MSP is very useful in the preparation and 
characterization of Nanodiscs. Typically the absorbance of tryptophan residues at 280 nm is 
utilized to track the time and shape of the peaks through the chromatography as well as to 
determine the concentration of the MSP in the final sample. In this case, however, the Gd chelate 
absorbs very strongly at 280 nm and overpowers the signal from the MSP, rendering it unusable 
for its regular functions.  In particular, it is important to make sure that the C3lipo and the MSP 
travel together through the SEC.  Tracking solely the C3lipo by 280 nm absorbance would not 
confirm that Nanodiscs were being formed, merely when the chelate itself was eluting (although 
the peaks were at approximately the right size for Nanodiscs). 
MSP was tagged with Uniblue, a dye that absorbs at 595 nm, where C3lipo does not.  During 
chromatography, the instrument reported both 280 and 595 nm channels simultaneously, and the 
chelate and the protein could be tracked in conjunction to ensure co-elution, as shown in Figure 
3.4.  In general, the two peaks were simultaneous, with the occasional slight shift that indicates 
that not all Nanodiscs contain exactly the same amount of chelate.  When determining which 
fractions to pool, the 595 nm trace was used since it better represented where the Nanodiscs were 
present. 
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The absorbance at 595 nm was also used to determine the Nanodisc concentration of the final 
solution.  The extinction coefficient for the dye, however, was not high, so in the future, another 
dye would prove more useful.  Cy5, a fluorescent dye, will be used because it can serve the same 
purposes, but also fluorescently track MSP in upcoming cell uptake studies. 
 
3.4 Protein to Lipid Ratio 
Another key parameter in proper Nanodisc formation is the ratio of membrane scaffold protein to 
lipids.  For DMPC Nanodiscs with no chelate included, the ratio has been well characterized as 
80:1 DMPC:MSP.
6
  However, the inclusion of the chelate could alter the packing of the lipids or 
their incorporation into Nanodiscs.  
Three different ratios of lipids (including 25% chelate) were tested, the 80:1 suggested by 
previous experimentation, as well as 90:1 and 100:1.  The 80:1 sample was very broad while the 
other two had much narrower shapes (Figure 3.4).  However, none of the chromatograms 
contained the peak at 16 minutes (Figure 1.3) that represents the excess lipid aggregates usually 
present in Nanodisc preps.  Also both the 90:1 and 100:1 samples came off the column at later 
times, signifying that they may have been under-lipidated.  In order to ensure adequate 
lipidation, ratios of 100:1 and 110:1 were frequently used.  At the time, the synthesis of C3lipo 
could not be routinely done and preserving the material was important.  Now that the synthesis is 
more routine, the optimization of lipid ratio should be done for different chelate dopings. 
 
3.5 Preliminary Results 
Members of the Meade lab at Northwestern have tested the chelate-doped Nanodiscs to 
determine their efficacy for in vivo contexts.  Phantom images of capillaries containing Nanodisc 
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solutions demonstrated that an increase in contrast could be accomplished by the use of 
Nanodiscs containing C3lipo, as opposed to pure water (Figure 3.5).   The relaxation times for 
30% and 15% doped Nanodiscs were measured at different concentrations. The T1 relaxation 
times decrease with increasing concentration of Nanodiscs, as they ought to with the increase of 
Gd. 
Additionally, Nanodiscs were monitored over time to determine if the chelate remained 
encapsulated within them or if it drifted out of the Nanodisc structure over time.  Figure 3.6 
shows that the relaxation times did not change (within error) for the 15% sample over the course 
of 3 weeks.  The 30% sample (Figure 3.7) did vary more than the error, but only by 2%.  This 
indicates that C3lipo is so hydrophobic that it remains within the Nanodisc structure over time. 
Preliminary cell uptake experiments have also been done to determine if the Gd infiltrates cells.  
Even at very low incubation concentrations, for 24 hours, Gd uptake was observed  (Figure 3.8).  
This is encouraging because in order to effectively image and track cells, the contrast agent must 
be introduced.  Without the use of Nanodiscs, this was impossible with C3lipo due to its 
insolubility in aqueous solutions.  A viability study also showed that neither the Nanodiscs nor 
the Gd chelate was causing cell death (Figure 3.9), indicating that neither the Nanodiscs nor the 
gadolinium in its chelate are toxic to the cells. 
The inclusion of Gd chelates into Nanodiscs is quite promising, but optimization is still required 
in order to make the loading and creation of Nanodiscs with C3lipo more efficient. 
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3.6 Figures 
 
Figure 3.1 The structure of C3lipo contains three chelated Gd atoms to create image contrast and 
two alkane chains to interact with cell membranes. 
 
 
 
 
Figure 3.2  Size exclusion chromatogram of a Nanodisc prep that contains 30% C3lipo. The 
shouldering on the late side of the peak means smaller Nanodiscs were also formed and that the 
results of the prep were not monodisperse. The two traces correspond to 280 and 595 nm, 
tracking the chelate and the dye on the MSP. 
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Figure 3.3  Size exclusion chromatogram of 15% C3lipo.  No significant broadening or 
shouldering is present, which indicates that the Nanodiscs formed were monodisperse.  The peak 
at around 16 minutes corresponds to lipid aggregates that were not included in the Nanodisc 
structures and is typical of Nanodisc preps. 
 
 
Figure 3.4  25% C3lipo Nanodiscs formed with 3 different ratios of lipid (including chelate) to 
MSP.  The lower ratio, usually used for DMPC Nanodiscs, created a very broad distribution of 
particles, while the higher ratios had better peak shapes. None, however, included excess lipid 
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aggregates at 16 minutes and the 100 and 90:1 samples came out later (and therefore were 
smaller) than typical Nanodiscs. 
 
 
Figure 3.5 MRI images of capillaries containing different concentrations of chelate doped 
Nanodiscs. The increase in Nanodisc concentration decreases the relaxation time of water and 
creates image contrast.  Figure and data courtesy of Christiane Carney and Dr. Tom Meade. 
 
 
Figure 3.6 The stability of the relaxation times of a 15% C3lipo Nanodisc sample indicates that 
Gd is not being lost from the Nanodisc structure and that the chelate remains imbedded in the 
Nanodiscs over the course of two weeks. Figure and data courtesy of Christiane Carney and Dr. 
Tom Meade. 
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Figure 3.7  The stability of the relaxation times of a 30% C3lipo Nanodisc sample over two 
weeks varies greater than the experimental error, but is still minor (2%) overall. Figure and data 
courtesy of Christiane Carney and Dr. Tom Meade. 
 
 
 
 
 
Figure 3.8  Cells incubated with doped Nanodiscs for 24 hours uptake Gd, even at very low 
concentrations. Figure and data courtesy of Christiane Carney and Dr. Tom Meade. 
 
 
 
82
84
86
88
90
92
94
96
98
100
Day 9  Day 16  Day 21
T1
 R
e
la
xa
ti
o
n
 t
im
e
 (
m
s)
 
Time Elapsed 
 42 
 
 
 
 
 
Figure 3.9  The viability of the cells is unaffected by the incorporation of Gd into Nanodiscs, or 
by the Nanodiscs themselves. Figure and data courtesy of Christiane Carney and Dr. Tom 
Meade.
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Chapter 4: Soluble Membrane Protein Libraries 
 
 
4.1 Background and Method 
Due to the large hydrophobic regions present in their structure, membrane proteins have been 
difficult to study in aqueous environments without the use of detergents, which are undesirable 
as they may alter the protein from its native structure.  As previously discussed, Nanodiscs have 
been used to overcome this issue for a large variety of integral membrane proteins.  In the 
majority of these studies, however, a previously purified protein is incorporated into the 
Nanodiscs and a disc population is formed that includes only the protein of interest.  A technique 
was developed to incorporate membrane proteins present in cell membranes into Nanodisc 
“libraries”.77 These soluble membrane protein libraries (SMPL) are composed of Nanodiscs that 
encapsulate many different proteins originating from native membranes.  With these proteins 
solubilized by the Nanodisc structure, assays such as pull-downs can be used to isolate and 
identify protein targets.  
For example, a physiological effect may be accomplished by a ligand that has been previously 
identified, but the target protein to which binding occurs may remain obscured.  The membrane 
proteins’ insolubility in aqueous buffers hinders their isolation and identification.  If the various 
proteins present in the membrane were translated into Nanodiscs, the proteins would both be 
soluble and easy to isolate.  The ligand could then be incubated with the library and allowed to 
bind to the target.  The ligand can then be purified (such as by affinity chromatography) with its 
binding partner still attached, while all the other membrane proteins are washed away.  The 
remaining proteins can be identified by proteomic techniques in order to identify the target.
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If a representative library can be formed in Nanodiscs, then the identification of membrane 
protein targets can be done in aqueous buffer without the hindrance of detergent.  However, if 
the library does not include a large selection of the proteins present in the native membrane, then 
the pull-down assay may not find and isolate the appropriate targets.  Therefore, it is important 
for SMPL techniques to faithfully incorporate a large fraction of the proteins present in the 
original membrane. 
The optimization of this technique for E. coli has previously been done, where the parameters 
such as the amount of lipids, detergent and scaffold protein added to the membrane extracts had 
been determined.
77
  In order to gain familiarity with the technique before applying it to new 
systems, the E. coli procedure was replicated (illustrated in Figure 4.1). 
An aliquot of the initial of DH5α isolated membranes was removed for later comparison to the 
library, and the remainder was centrifuged at 12,000 RPM for 30 minutes.  The supernatant was 
removed and was replaced with approximately the same volume of detergent.  In these 
experiments 1% n-Dodecyl β-D maltopyranoside (DDM) was used as the solubilizing detergent 
added to the membrane pellet.  The mixture was vortexed and sonicated for 15 minutes in order 
to extract the proteins from the membranes and was centrifuged again at 12,000 RPM for 15 
minutes.  The supernatant was kept and a BCA assay was performed to determine the total 
concentration of membrane proteins solubilized by the detergent.  
MSP1E3D1, a scaffold protein with extra helices compared to MSP1D1 to create larger 
Nanodiscs,
5
 was added to the solution at a ratio of 1 nanomole of MSP per 10 µg of membrane 
protein.  POPC solubilized in sodium cholate was also added at a ratio of 100:1 lipid to MSP.   
The detergent solubilized membrane proteins, lipids and MSP were allowed to incubate with 
extra sodium cholate at 4°C for several hours.  Then 0.6 g of hydrophobic Amberlite XAD-2 
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beads were added per milliliter of reconstitution mixture.  The beads remove the detergent and 
initiate the self-assembly process of the Nanodiscs.   The mixture was incubated with the beads 
overnight and afterwards, the solution was removed from the beads and filtered through a 0.22 
µm filter. 
The fully formed Nanodiscs were purified from the unassembled components by affinity 
chromatography.  The MSP1E3D1 protein includes a poly-histidine tag which binds it to the 
nickel NTA column while the other components wash through. At this stage intact Nanodiscs 
can be eluted from the column and analyzed by size exclusion chromatography or utilized for 
further library experimentation. 
In order to simply analyze the preservation of proteins from the membranes to the Nanodisc 
library, the MSP can remain bound to the column.  Cholate buffer (20 mM Tris, 100 mM NaCl, 
50 mM sodium cholate) was run through the column and served to resolubilize the Nanodisc 
components.  The MSP remained attached to the column while the interior components, 
including the encapsulated membrane proteins, flowed through.  The fractions of this elution 
were analyzed by BCA to pool those that contained proteins.  The pooled sample was 
concentrated and analyzed by another BCA assay.  The volumes required for 10, 12, 15 and 17 
µg of protein were removed from the sample and each was precipitated by a methanol-
chloroform-water extraction.
77
  Corresponding amounts from the original raw membrane aliquot 
and the detergent solubilization step were treated the same way. The precipitated proteins were 
dried and dissolved in Laemmli buffer and warmed to 65°C for 5 minutes to enhance 
solubilization.  The samples were loaded and run on a Bio Rad Mini-PROTEAN TGX 12% 
PAGE gel and stained with Imperial Protein Stain.  The gel (Figure 4.2) shows that bands present 
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in the original membrane are carried through the detergent solubilization and Nanodisc formation 
to create a faithful library of the E. coli membrane. 
The gel shows preservation of bands between the experimental steps.  Proteins that were present 
in the raw membrane are solubilized by the DDM and then do end up within Nanodiscs, making 
a library with high fidelity to the original membrane.  However, the MSP did not entirely remain 
attached to the column and forms large, dark bands on the gel.   
 
4.2 Brain and Liver Membranes 
Membranes from adult rat (Rattus norvegicus) liver and two different weight fractions from fetal 
bovine (Bos Taurus) brains were donated by the Brieher lab. The method previously described 
was implemented with these new membranes.  Without further optimization, the gel shows a 
large number of bands that persist throughout the SMPL procedure.  An estimate shows that 
about 75% of proteins that are visible in the detergent extract lane are present in the Nanodisc 
library (Figure 4.3). 
One persisting difficulty was the presence of MSP in the SMPL lanes of the gel.  Clearly not all 
of the MSP is remaining attached to the Ni-NTA column.  A liver SMPL prep was formed and 
the MSP was so strongly present that it overpowered the rest of the proteins.  The sample was 
run through the Ni-NTA column again, and while the MSP was still present, other proteins 
became visible (Figure 4.4).  Using newer resin or slightly changing the elution buffer will 
rectify this issue. However, The success of the libraries formed with these two membrane types 
is encouraging for the application of this technique to many different cell types and applications. 
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4.3 Figures 
 
 
Figure 4.1 In order to create soluble membrane protein libraries, detergent is used to extract 
proteins from biological membranes.  This detergent extract is incubated with MSP, lipids and 
cholate and when the detergent is removed, Nanodiscs assemble including the membrane 
proteins originating from the biological membrane. 
 
Figure 4.2 
Lane 1: Standard ladder 
Lane 2: Raw E. Coli membrane 
Lane 3: Detergent solubilized 
Lane 4: Nanodisc library (10 µg) 
Lane 5: Nanodisc library (12 µg) 
Lane 6: Nanodisc library (15 µg) 
Lane 7: Nanodisc library (17 µg) 
 
This gel demonstrates that membrane 
proteins present in the original E. coli 
membrane are carried through the process 
to be represented in Nanodisc libraries.  
The large, dark bands in the middle 
represent MSP and somewhat obscure the 
gel. 
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Figure 4.3 Demonstrates the effectiveness of the SMPL process for three sets of mammalian 
cells. A large percentage of proteins present in the original membranes are preserved through the 
process and are present in the Nanodisc libraries. A computer aided visual inspection
77
 concludes 
that 75% of the bands present in the detergent solubilized lanes are also present in the final 
SMPL. 
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Figure 4.4 MSP flowed through the Ni NTA column so prevalently that it overpowers all other 
proteins in this liver membrane sample.  After running the final sample through the column 
again, sufficient MSP is removed that the other membrane proteins become visible. However, 
excess MSP is still present. 
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